Mumbai, 18 Sept 2024: The Indian Patent Office is set to hear objections against patent claims filed by US-based pharmaceutical giant Gilead Sciences on HIV prevention drug “Lenacapavir”. Sankalp Rehabilitation Trust, a civil society organisation working with vulnerab......
View Details

Related News

• CDRI research a ray of hope for triple negative breast cancer patients (06-01-2025)

---

• CDSCO releases draft standard evaluation protocols for issuing license for IVDs (06-01-2025)

---

• Complaints filed with FDA and CMO against Solapur Ayush manufacturer; owner refutes allegations (05-01-2025)

---

• MP FDA forms joint team with Centre to ensure revised Schedule M compliance in pharma cos (05-01-2025)

---

• Draft notification for extension of Schedule M published for comments (04-01-2025)

---

• Illegal medical shop busted in Hyderabad (04-01-2025)

---

• Rajasthan: Registration of psychiatric hospitals, doctors will be mandatory (04-01-2025)

---

• TSMC serves notice to Rushcare Hospitals for its alleged association with quacks (04-01-2025)

---

• Pharma teachers faking profiles at multiple institutions, face being blacklisted (04-01-2025)

---

• DCA officials seize falsely manufactured Calcium tablets worth Rs 1.5 lakh (04-01-2025)

---